Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: A controlled cross-over randomized study

Gian Gastone Neri Serneri, Rosanna Abbate, Domenico Prisco, Marino Carnovali, Antonio Fazi, Gian Carlo Casolo, Francesco Bonechi, Pier Giorgio Rogasi, Gian Franco Gensini

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Increased thrombin generation is frequently associated with an increase in anginal activity. A cross-over, single-blind, completely randomized study was planned in order to evaluate whether the control of thrombin generation affected the increase in anginal activity. After discharge from the hospital, 24 patients (18 men and 6 women, aged 40 to 69 years) suffering from spontaneous angina were followed up to 12 months and were alternatively treated during two consecutive 6-month periods with calcium heparin, 12,500 IU by the subcutaneous route, or with placebo by the intramuscular route, in addition to the usual antianginal medications. Thrombin generation and clinical activity of angina were assessed every 15 days by measuring fibrinopeptide A (FPA) plasma levels and by grading in three classes (symptomiess, mildly symptomatic, and severely symptomatic) the anginal activity on the basis of the number and the time concentration of the ischemic attacks and ECG changes. Low-dose heparin treatment significantly reduced both the FPA plasma level (from 4.1 ± 3.7 to 2.3 ± 1.8 ng/ml, p <0.001) and the clinical activity of angina. During heparin treatment, the frequency of the observations in the severely and mildly symptomatic classes decreased, respectively, by 53% and by 30%, whereas that in the symptomless class increased by 23% (p <0.001) in comparison with the period on placebo. Present results indicate that the control of thrombin generation obtained by low-dose heparin treatment favorably affects the degree of anginal activity in patients with spontaneous angina.

Original languageEnglish
Pages (from-to)60-67
Number of pages8
JournalAmerican Heart Journal
Volume115
Issue number1 PART 1
DOIs
Publication statusPublished - 1988

Fingerprint

Thrombin
Cross-Over Studies
Heparin
Fibrinopeptide A
Placebos
Electrocardiography
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Neri Serneri, G. G., Abbate, R., Prisco, D., Carnovali, M., Fazi, A., Casolo, G. C., ... Gensini, G. F. (1988). Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: A controlled cross-over randomized study. American Heart Journal, 115(1 PART 1), 60-67. https://doi.org/10.1016/0002-8703(88)90518-2

Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin : A controlled cross-over randomized study. / Neri Serneri, Gian Gastone; Abbate, Rosanna; Prisco, Domenico; Carnovali, Marino; Fazi, Antonio; Casolo, Gian Carlo; Bonechi, Francesco; Rogasi, Pier Giorgio; Gensini, Gian Franco.

In: American Heart Journal, Vol. 115, No. 1 PART 1, 1988, p. 60-67.

Research output: Contribution to journalArticle

Neri Serneri, GG, Abbate, R, Prisco, D, Carnovali, M, Fazi, A, Casolo, GC, Bonechi, F, Rogasi, PG & Gensini, GF 1988, 'Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: A controlled cross-over randomized study', American Heart Journal, vol. 115, no. 1 PART 1, pp. 60-67. https://doi.org/10.1016/0002-8703(88)90518-2
Neri Serneri, Gian Gastone ; Abbate, Rosanna ; Prisco, Domenico ; Carnovali, Marino ; Fazi, Antonio ; Casolo, Gian Carlo ; Bonechi, Francesco ; Rogasi, Pier Giorgio ; Gensini, Gian Franco. / Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin : A controlled cross-over randomized study. In: American Heart Journal. 1988 ; Vol. 115, No. 1 PART 1. pp. 60-67.
@article{500a98b8cc744e23a360f82235ceb7c5,
title = "Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin: A controlled cross-over randomized study",
abstract = "Increased thrombin generation is frequently associated with an increase in anginal activity. A cross-over, single-blind, completely randomized study was planned in order to evaluate whether the control of thrombin generation affected the increase in anginal activity. After discharge from the hospital, 24 patients (18 men and 6 women, aged 40 to 69 years) suffering from spontaneous angina were followed up to 12 months and were alternatively treated during two consecutive 6-month periods with calcium heparin, 12,500 IU by the subcutaneous route, or with placebo by the intramuscular route, in addition to the usual antianginal medications. Thrombin generation and clinical activity of angina were assessed every 15 days by measuring fibrinopeptide A (FPA) plasma levels and by grading in three classes (symptomiess, mildly symptomatic, and severely symptomatic) the anginal activity on the basis of the number and the time concentration of the ischemic attacks and ECG changes. Low-dose heparin treatment significantly reduced both the FPA plasma level (from 4.1 ± 3.7 to 2.3 ± 1.8 ng/ml, p <0.001) and the clinical activity of angina. During heparin treatment, the frequency of the observations in the severely and mildly symptomatic classes decreased, respectively, by 53{\%} and by 30{\%}, whereas that in the symptomless class increased by 23{\%} (p <0.001) in comparison with the period on placebo. Present results indicate that the control of thrombin generation obtained by low-dose heparin treatment favorably affects the degree of anginal activity in patients with spontaneous angina.",
author = "{Neri Serneri}, {Gian Gastone} and Rosanna Abbate and Domenico Prisco and Marino Carnovali and Antonio Fazi and Casolo, {Gian Carlo} and Francesco Bonechi and Rogasi, {Pier Giorgio} and Gensini, {Gian Franco}",
year = "1988",
doi = "10.1016/0002-8703(88)90518-2",
language = "English",
volume = "115",
pages = "60--67",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1 PART 1",

}

TY - JOUR

T1 - Decrease in frequency of anginal episodes by control of thrombin generation with low-dose heparin

T2 - A controlled cross-over randomized study

AU - Neri Serneri, Gian Gastone

AU - Abbate, Rosanna

AU - Prisco, Domenico

AU - Carnovali, Marino

AU - Fazi, Antonio

AU - Casolo, Gian Carlo

AU - Bonechi, Francesco

AU - Rogasi, Pier Giorgio

AU - Gensini, Gian Franco

PY - 1988

Y1 - 1988

N2 - Increased thrombin generation is frequently associated with an increase in anginal activity. A cross-over, single-blind, completely randomized study was planned in order to evaluate whether the control of thrombin generation affected the increase in anginal activity. After discharge from the hospital, 24 patients (18 men and 6 women, aged 40 to 69 years) suffering from spontaneous angina were followed up to 12 months and were alternatively treated during two consecutive 6-month periods with calcium heparin, 12,500 IU by the subcutaneous route, or with placebo by the intramuscular route, in addition to the usual antianginal medications. Thrombin generation and clinical activity of angina were assessed every 15 days by measuring fibrinopeptide A (FPA) plasma levels and by grading in three classes (symptomiess, mildly symptomatic, and severely symptomatic) the anginal activity on the basis of the number and the time concentration of the ischemic attacks and ECG changes. Low-dose heparin treatment significantly reduced both the FPA plasma level (from 4.1 ± 3.7 to 2.3 ± 1.8 ng/ml, p <0.001) and the clinical activity of angina. During heparin treatment, the frequency of the observations in the severely and mildly symptomatic classes decreased, respectively, by 53% and by 30%, whereas that in the symptomless class increased by 23% (p <0.001) in comparison with the period on placebo. Present results indicate that the control of thrombin generation obtained by low-dose heparin treatment favorably affects the degree of anginal activity in patients with spontaneous angina.

AB - Increased thrombin generation is frequently associated with an increase in anginal activity. A cross-over, single-blind, completely randomized study was planned in order to evaluate whether the control of thrombin generation affected the increase in anginal activity. After discharge from the hospital, 24 patients (18 men and 6 women, aged 40 to 69 years) suffering from spontaneous angina were followed up to 12 months and were alternatively treated during two consecutive 6-month periods with calcium heparin, 12,500 IU by the subcutaneous route, or with placebo by the intramuscular route, in addition to the usual antianginal medications. Thrombin generation and clinical activity of angina were assessed every 15 days by measuring fibrinopeptide A (FPA) plasma levels and by grading in three classes (symptomiess, mildly symptomatic, and severely symptomatic) the anginal activity on the basis of the number and the time concentration of the ischemic attacks and ECG changes. Low-dose heparin treatment significantly reduced both the FPA plasma level (from 4.1 ± 3.7 to 2.3 ± 1.8 ng/ml, p <0.001) and the clinical activity of angina. During heparin treatment, the frequency of the observations in the severely and mildly symptomatic classes decreased, respectively, by 53% and by 30%, whereas that in the symptomless class increased by 23% (p <0.001) in comparison with the period on placebo. Present results indicate that the control of thrombin generation obtained by low-dose heparin treatment favorably affects the degree of anginal activity in patients with spontaneous angina.

UR - http://www.scopus.com/inward/record.url?scp=0023833745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023833745&partnerID=8YFLogxK

U2 - 10.1016/0002-8703(88)90518-2

DO - 10.1016/0002-8703(88)90518-2

M3 - Article

C2 - 3276111

AN - SCOPUS:0023833745

VL - 115

SP - 60

EP - 67

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1 PART 1

ER -